Table 1 |
|||
|
Types of diseases |
|||
|
Type |
Definition |
Example |
Barriers to therapy in developing countries |
|
|
|||
|
Type 1 |
Diseases that are incident in both developed and developing countries with large numbers of vulnerable populations in both groups of countries |
Diabetes |
No market incentive to invest in interventions adapted to the resources and social and economic conditions of developing countries |
|
|
|||
|
Type 2 |
Diseases that are incident in both developed and developing countries but with a substantial proportion of the cases in developing countries |
HIV |
Type or strain of disease different in developed and developing countries |
|
|
|||
|
Type 3 |
Diseases that are overwhelmingly or exclusively incident in developing countries |
Chagas disease |
No market incentive to invest in research |
|
|
|||
|
Lexchin BMC International Health and Human Rights 2010 10:20 doi:10.1186/1472-698X-10-20 |
|||
